12:00 AM
 | 
Jul 31, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Anti-CD20 antibodies regulatory update

CLTR received U.S. Patent No. 6,090,365 covering the use of unlabeled antibodies against the CD20 B cell antigen in...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >